Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Radical Collaboration. Real-World Impact.
Texas expertise fuels the discovery and delivery of next-generation preventions, diagnoses, treatments and cures.
LET'S GO
World Class. Close to Home.
We’re working to make seamless, person-centered care the standard in Central Texas and beyond.
Get Care
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory

Robert Feldman, M.D.

Education

M.D.
Chicago Medical School, Rosalind Franklin University

Residency/Fellowship

Internship, Internal Medicine
New York Infirmary

Residency, Ophthalmology
University of California San Diego

Fellowship in Glaucoma
Baylor College of Medicine

About

Robert Feldman, M.D., is an internationally recognized glaucoma specialist with more than three decades of experience advancing the diagnosis, treatment and understanding of glaucoma. He currently serves as a professor of Ophthalmology and Associate Chair for Research in the Department of Ophthalmology, where he leads efforts to build the missions of the academic ophthalmology program.

Prior to joining Dell Medical School, Dr. Feldman served as Chairman of the Department of Ophthalmology and Visual Science at McGovern Medical School, UT Health Houston, for over a decade, later continuing as clinical professor, director of the Glaucoma Service and director of Clinical Research. He has held the Eunice Hermes Davidson Distinguished University Chair and the Ruiz Distinguished University Chair.

Dr. Feldman has trained generations of ophthalmologists through residency programs, glaucoma fellowships, national and international lectures, and hands-on surgical wet labs. He has served as an advisor to leading pharmaceutical companies including Alcon, Pfizer, Bausch + Lomb, and Santen, and co-founded 4DMD, a biotech startup focused on innovative medical devices.